技术进步定义了从正常转移信号通路到原发性和转移性结直肠癌的信号通路
Robert G Ramsay1,2, Vicki Whitehall3,4, Michael P Flood1
1Sir Peter MacCallum Department of Oncology and Peter MacCallum Cancer Centre, The University of Melbourne, Parkville, Australia.
Growth factors (Chur, Switzerland)
|June 23, 2023
概括
有机体和瘤体模型通过模仿瘤及其微观环境,为研究结直肠癌 (CRC) 提供了新的途径. 这些患者衍生模型加速了化学疗法和免疫疗法等疗法的测试.
科学领域:
- 瘤学和癌症生物学
- 胃肠病学 胃肠病学
- 3D细胞培养和机体技术
背景情况:
- 肠道上皮质的有机和瘤传播提供了一个平台来比较细胞依赖.
- 这些3D模型总结了瘤基因表达和瘤微环境 (TME).
- 通过添加淋巴细胞和与癌症相关的纤维细胞等组件来操纵TME.
研究的目的:
- 探索有机体/瘤体模型在理解结肠直肠癌 (CRC) 生物学方面的实用性.
- 调查这些模型在快速治疗测试中的潜力.
- 为CRC研究利用有机体技术和单细胞RNA测序 (scRNAseq) 的进步.
主要方法:
- 正常和恶性肠道上皮质有机体/瘤体的传播.
- 纳入和操纵瘤微环境组件 (如淋巴细胞,纤维细胞).
- 单细胞RNA测序 (scRNAseq) 的应用用于详细的分子分析.
- 测试各种疗法的疗效,包括化疗,放射治疗和免疫治疗.
主要成果:
- 有机体/瘤体模型准确地反映了瘤基因表达和TME贡献.
- 治疗效果 (化疗,放射,免疫疗法) 可以在几周内评估.
- 这些模型提供患者特定的瘤化身,以获得个性化的治疗见解.
- 在有机体传播和scRNAseq方面的进步正在完善对结直肠癌亚型 (CMS) 的理解.
结论:
- 有机体/瘤体模型是研究结直肠癌 (CRC) 和其微观环境的强大工具.
- 这些来自患者的化身能够快速和个性化地进行治疗查.
- 新兴技术正在改变CRC亚型的分类和理解.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.8K
09:16High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor
Published on: June 14, 2018
10.1K
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
